INSIGHTS •   •   •   •   •   •   •   •   •   •   •  

By Ken Kahtava on 3/13/2013 11:01 AM
Excellent compendium from our friends at FasterCures of the people, organizations and partnerships being developed to accelerate treatments to patients with unmet medical needs.
By Ken Kahtava on 12/10/2012 3:05 PM
In summarizing his take on the recent Partnering for Cures conference in NY, Pfizer's head of R&D, Mikael Dolsten proclaims that even the world's largest pharmaceutical company can not, and should not, go it alone.
By Ken Kahtava on 9/13/2012 3:22 PM
Majority of rare disease patients turn to patient advocacy groups as singular source of clinical trial information.